Dr. Morgan is the Medical Director for the INTEGRIS James R. Daniel Stroke Center of Oklahoma™. He graduated from the University of Oklahoma Medical School in 1972 and has been a licensed physician since 1973 in Oklahoma. He completed his medical internship between 1972 – 1973 at Vanderbilt University in Nashville, Tennessee, and his residency at University of Oklahoma Health Sciences Center, 1973 – 1978.
Dr. Morgan has been board certified in Neurology by the American Board of Psychiatry and Neurology since 1980. In 2009 he joined five other physicians in the state of Oklahoma as a board Certified Vascular Neurologist.
He has maintained teaching appointments throughout his neurology practice, and currently is a Clinical Assistant of Neurology at the University of Oklahoma Health Sciences Center, which involves supervision of medical residents at INTEGRIS Southwest Medical Center. He also has been instrumental in initiating a monthly Neurology Ground Rounds in collaboration with the ISMC Emergency Department physicians, nurses, and residents. In addition to providing professional education to medical staff, Dr. Morgan has a strong commitment to educating our community on the warning signs and risk factors of stroke, both within our state and across the nation.
Since 1997, he has been a faculty member for Medical Education Resources, which is designed to teach post-graduate internists, family medicine physicians, and emergency room physicians about clinical neurology.
Dr. Morgan has held multiple medical directorships. He is currently a member of the American Medical Association, Oklahoma State Medical Association, Oklahoma County Medical Association, American Academy of Neurology and the Oklahoma Neurological Society. He also is the co-chair for the American Heart Association’s Oklahoma State Stroke Task Force.
He has served as the neurology consultant for a CDC grant awarded to Emory University’s Rollins School of Public Health in Atlanta, Georgia, on a Prospective Study of Stroke Outcomes. He also was the Primary Investigator for a clinical drug trial sponsored by Astra Zeneca, Saints II Clinical Trial, to assess the efficacy and safety of intravenous NXY-059 in acute ischemic stroke.
Dr. Morgan provides coverage and services in the inpatient, outpatient, and TeleHealth settings with a dedication to excellence. He and his six partners (Dr. Brent Beson, Dr. Gabriel Pitman, Dr. Harvey Drapkin, Dr. Timothy Rathbun, Dr. Farhat Husain, and Dr. Joshua Kershen) provide 24/7/365 neurology coverage to the INTEGRIS Southwest Neuroscience Institute.
To schedule an appointment with Dr. Morgan, please call Southwest Neurological Associates at 405-644-5160.